Phenotype measures set:   Mills1   late_apoptotic

ID, description, units MPD:25211   late_apoptotic   late apoptotic splenocytes   [%]
Measures • 6mo    • 12mo    • 20mo
Data set, strains Mills1   inbred   7 strains     sex: both
Procedure apoptosis assessment
Comparisonaging-study, multiple cohorts
Ontology mappings

  SIDE-BY-SIDE STRAIN CURVES
Values
Graph Type
Dimensions Width:  ×  Height: px
Plot Options


  OVERLAPPING STRAIN CURVES
Data
Dimensions px
Toggle Series   
Plot Options

Mills1 - late apoptotic splenocytes





  ANOVA, Q-Q NORMALITY ASSESSMENT

ANOVA Summary     

Factor DF Sum of squares Mean sum of squares F value p-value (Pr>F)
age 2 22.7436 11.3718 7.9922 0.0009
sex 1 4.0407 4.0407 2.8399 0.0978
strain 3 47.2864 15.7621 11.0778 < 0.0001
age:sex 2 18.0013 9.0006 6.3257 0.0034
age:strain 6 8.9547 1.4925 1.0489 0.4048
sex:strain 3 9.9773 3.3258 2.3374 0.0841
age:sex:strain 6 23.2313 3.8719 2.7212 0.0223
Residuals 53 75.4117 1.4229

Q-Q normality assessment based on residuals

  


  INDIVIDUAL MEASURES
ProjectIDDrug or
challenge
Description and varname PanelStrains
tested
SexAge
Mills1 25211 apoptosis assessment (none) late apoptotic splenocytes   [%]   at age 6mo   late_apoptotic_M06 inbred 7 both 26wks
Mills1 25212 apoptosis assessment (none) late apoptotic splenocytes   [%]   at age 12mo   late_apoptotic_M12 inbred 29 both 52wks
Mills1 25213 apoptosis assessment (none) late apoptotic splenocytes   [%]   at age 20mo   late_apoptotic_M20 inbred 28 both 87wks